Lisata Therapeutics, Inc. (LSTA)
Nasdaq: LSTA · Pharmaceutical Preparations · Basking Ridge, NJ · filing with the SEC since 1995
Who owns Lisata Therapeutics, Inc.
As filed with the SECHolders of 5% or more
1
Branham Justin Earl holds 5.1% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G filed Aug 26, 2026 says.
Directors and officers
11
report now, of 24 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Branham Justin Earl
SCHEDULE 13G · filed Aug 26, 2026 · Common Stock, par value $0.001 per share
What LSTA reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Impilo
An investee · investee · invested in, named in the 10-K filed Mar 12, 2026
Kuva
A company bought · acquisition · owns, named in the 10-K filed Mar 12, 2026
6 subsidiaries in 5 countries, from the list filed with the 10-K filed Mar 12, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2021 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.